[Nutrition and physical activity (PA) during and after cancer treatment: Therapeutic benefits, pathophysiology, recommendations, clinical management].
Nutrition et activité physique adaptée (APA) pendant et après les traitements du cancer : bénéfices thérapeutiques, physiopathologie, recommandations, prise en charge clinique.
Activité physique adaptée
Adapted physical activity
Cancer
Conseil diététique
Deconditioning
Dietary counselling
Déconditionnement
Fatigue
Sarcopenia
Sarcopénie
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
15
02
2022
accepted:
24
02
2022
pubmed:
1
5
2022
medline:
31
5
2022
entrez:
30
4
2022
Statut:
ppublish
Résumé
Lifestyle behaviors, such as diet and physical activity, are factors that influence risk of numerous cancers. They are also decisive during and after cancer for the course of oncological treatment, but also in the immediate and long-term prognosis, and quality of life during and after treatment. Separately, physical activity and nutritional support can reduce the risk of sarcopenia and its consequences, and improve quality of life during treatment. Whan introduced early, such a combination, increases the prognostic benefits. In remission, particularly in overweight patients, the APA-diet combination reduces the risk of cancer relapse and improves cardiovascular performance. These programs require a precise assessment of capacities and habits of each patient, and interventions of trained professionals (certified exercise instructor, dietician trained in oncology). The funding conditions for these programs exist for cancer survivors and should be considered for oncological treatment period.
Identifiants
pubmed: 35489872
pii: S0007-4551(22)00082-0
doi: 10.1016/j.bulcan.2022.02.008
pii:
doi:
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
516-527Informations de copyright
Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.